Latest Insider Transactions at Cocrystal Pharma, Inc. (COCP)
This section provides a real-time view of insider transactions for Cocrystal Pharma, Inc. (COCP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cocrystal Pharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cocrystal Pharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 09
2024
|
Fred Hassan Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,067
+0.78%
|
-
|
|
Oct 09
2024
|
Anthony J Japour Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,924
+50.0%
|
-
|
|
Oct 09
2024
|
James Joseph Martin Co-CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+49.65%
|
-
|
|
Oct 09
2024
|
Richard C Pfenniger Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,067
+41.44%
|
-
|
|
Oct 09
2024
|
Sam Lee President and Co-CEO |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+34.38%
|
-
|
|
Oct 09
2024
|
Steven D Rubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,957
+0.71%
|
-
|
|
Oct 09
2024
|
Phillip Md Et Al Frost Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,100
+50.0%
|
-
|
|
Oct 09
2024
|
Roger D. Kornberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,109
+50.0%
|
-
|
|
Apr 04
2023
|
Phillip Md Et Al Frost Director |
BUY
Open market or private purchase
|
Indirect |
1,015,229
+43.48%
|
$1,015,229
$1.97 P/Share
|
|
Aug 20
2021
|
Richard C Pfenniger Jr Director |
BUY
Open market or private purchase
|
Direct |
40,000
+50.0%
|
$40,000
$1.03 P/Share
|
|
May 04
2021
|
Raymond F Schinazi > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
575,000
-6.97%
|
$1,150,000
$2.95 P/Share
|